相似文献
1
The pathergy test and Behçet's syndrome in Britain.
Ann Rheum Dis. 1984 Feb;43(1):70-3. doi: 10.1136/ard.43.1.70.
2
The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
J Rheumatol. 1980 Mar-Apr;7(2):206-10.
3
Behçet's disease in Iraqi patients.
Ann Rheum Dis. 1986 Dec;45(12):987-90. doi: 10.1136/ard.45.12.987.
4
A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease.
Ann Rheum Dis. 1984 Feb;43(1):74-5. doi: 10.1136/ard.43.1.74.
5
Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
Rheumatology (Oxford). 2012 May;51(5):887-900. doi: 10.1093/rheumatology/ker428. Epub 2012 Jan 11.
6
Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Curr Rheumatol Rev. 2020;16(2):120-124. doi: 10.2174/1573397115666190918153721.
7
A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
Tissue Antigens. 1997 Jul;50(1):57-60. doi: 10.1111/j.1399-0039.1997.tb02835.x.
8
Close association of HLA-Bw51 with Behçet's disease.
Arch Ophthalmol. 1982 Sep;100(9):1455-8. doi: 10.1001/archopht.1982.01030040433013.
9
HLA antigens and linkage disequilibrium patterns in Turkish Behçet's patients.
J Dermatol. 1998 Mar;25(3):158-62. doi: 10.1111/j.1346-8138.1998.tb02372.x.
10
Comparative study of the skin pathergy test with blunt and sharp needles in Behçet's disease: confirmed specificity but decreased sensitivity with sharp needles.
Ann Rheum Dis. 1993 Nov;52(11):823-5. doi: 10.1136/ard.52.11.823.
引用本文的文献
1
Behçet Disease: An Update for Dermatologists.
Am J Clin Dermatol. 2021 Jul;22(4):477-502. doi: 10.1007/s40257-021-00609-4. Epub 2021 Jun 1.
2
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.
Intern Emerg Med. 2021 Nov;16(8):2163-2171. doi: 10.1007/s11739-021-02725-9. Epub 2021 Apr 9.
3
Diagnostic Sensitivity of Different Applications of Pathergy Test for Behçet's Disease.
Arch Rheumatol. 2019 Apr 15;35(1):29-34. doi: 10.5606/ArchRheumatol.2020.7380. eCollection 2020 Mar.
4
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.
Intern Emerg Med. 2020 Sep;15(6):1031-1039. doi: 10.1007/s11739-019-02248-4. Epub 2020 Feb 1.
5
Behcet's Disease With Cerebral Artery Infarction Caused by Cerebral Arteritis as an Early Symptom Only With Elevated Interleukin-8.
Front Neurol. 2019 Oct 22;10:1102. doi: 10.3389/fneur.2019.01102. eCollection 2019.
6
The real-world use of different anti-tumor necrosis factor agents in a Northern European population of patients with Behçet's disease.
Eur J Rheumatol. 2017 Dec;4(4):254-259. doi: 10.5152/eurjrheum.2017.17046. Epub 2017 Nov 2.
7
Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.
Int J Rheumatol. 2017;2017:2160610. doi: 10.1155/2017/2160610. Epub 2017 Sep 10.
8
A New Diagnostic Way for Behcet's Disease: Skin Prick with Self-Saliva.
Genet Res Int. 2014;2014:581468. doi: 10.1155/2014/581468. Epub 2014 Jan 23.
9
[Behçet's disease - ophthalmological and general aspects part I : etiology, pathogenesis and diagnostics].
Ophthalmologe. 2012 Nov;109(11):1129-41; quiz 1142-3. doi: 10.1007/s00347-012-2698-5.
10
Differential diagnosis and management of Behçet syndrome.
Nat Rev Rheumatol. 2013 Feb;9(2):79-89. doi: 10.1038/nrrheum.2012.156. Epub 2012 Sep 25.
本文引用的文献
1
The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's disease in Turkey.
J Rheumatol. 1980 Mar-Apr;7(2):206-10.
2
Polymorphonuclear function in Behçet's syndrome.
Ann Rheum Dis. 1982 Aug;41(4):421-5. doi: 10.1136/ard.41.4.421.
3
Behçet's syndrome with arthritis.
Ann Rheum Dis. 1969 Mar;28(2):95-103. doi: 10.1136/ard.28.2.95.
4
Behçet's disease. Report of 10 cases, 3 with new manifestations.
Ann Intern Med. 1971 Oct;75(4):561-70. doi: 10.7326/0003-4819-75-4-561.
5
Behçet's disease. Report of twelve cases with three manifesting as papilledema.
Am J Med. 1970 Dec;49(6):823-9. doi: 10.1016/s0002-9343(70)80064-x.
6
Summary of International Symposium on Behçet's Disease. Istanbul, September 29-30, 1977.
J Rheumatol. 1978 Summer;5(2):229-33.
7
The high prevalence of HLA-B5 in Behçet's disease.
Clin Exp Immunol. 1977 Nov;30(2):259-61.
8
Behcet's syndrome in 32 patients in Yorkshire.
Ann Rheum Dis. 1977 Dec;36(6):491-99. doi: 10.1136/ard.36.6.491.
9
The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behçet's disease in Turkey.
Acta Derm Venereol. 1979;59(1):77-9.
10
Leucocyte movement and colchicine treatment in Behcet's disease.
Lancet. 1975 Oct 25;2(7939):813. doi: 10.1016/s0140-6736(75)80031-6.
Zotero 插件